This study aimed to evaluate the prognostic value of KIT and PDGFRA mutation subtypes in a large‐scale cohort of Chinese patients with GIST after treatment with the current therapy including surgery and imatinib treatment. Here, KIT is linked to gastrointestinal stromal tumor.